But in July the FDA declared the drug an "imminent hazard to the public health" and gave doctors 90 days to switch to an alternative treatment (such as insulin, dietary restrictions or other drugs).
However, in July, the FDA deemed the medication a "substantial risk to public well-being" and instructed physicians to transition patients to alternative therapies, such as insulin, dietary adjustments, or other medications, within a 90-day timeframe.